Canadian Sciences Speakers Network

Réseau Canadien de Panélistes Scientifiques


Glen Pyle: CSSN Speaker

Glen Pyle

Hamilton, Ontario

Position: Professor

Organization: University of Guelph, IMPART Network at Dalhousie Medicine, and Women’s Health Research Institute at BC Women’s HospitalBC Women’s

Glen Pyle is a Professor of Molecular Cardiology and a member of the IMPART Network at Dalhousie Medicine and the Women’s Health Research Institute at BC Women’s Hospital. His lab focuses on women’s cardiovascular health, including the impacts of menopause and intimate partner violence on heart attack deaths, and the development of therapies to reduce these risks. The team was the first to identify how the hearts of women are altered during the transition to menopause (“perimenopause”) and explain how these changes contribute to the higher risk of cardiovascular disease death in postmenopausal women. In 2024, the team received funding from the National Women’s Health Research Initiative to investigate the relationship between intimate partner violence or “domestic abuse” and an increase in heart attack mortality in women. The Laboratory for Women’s Heart Health (www.womensheartlab.com) has been supported with grants from the Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research, National Sciences and Engineering Research Council of Canada, and the U.S. National Institutes of Health.

Areas of Expertise:

+ Women’s Heart health
+ Menopause
+ Sex differences

Language(s):

+ English


My Work

What I do:

Our lab is investigating how sex differences in the heart impact heart disease risk. Specifically we are interested in how menopause and intimate partner violence impact women’s risk of dying from heart attacks. We use animals models to determine the mechanisms of risk at the molecular level, and develop interventions that may lower these risks.

Ask me about:

Women’s heart health; menopause; intimate partner violence and cardiovascular disease; sex differences in cardiovascular disease

Why me:

We are among the first to identify how the heart changes during the perimenopausal transition at the molecular level. We have identified early changes in animal models of menopause that may contribute to the increased risk of cardiovascular disease mortality seen in postmenopausal women. We are actively engaged in communicating our work and the current state of women’s cardiovascular health to both our professional peers, and the public at large. We regularly speak at public gatherings and have given numerous media interviews.


About Me

Sector: Academia (Post Secondary)

English proficiency: Read, Write, Speak

Title: Dr.

Pronouns: He/Him/His

Gender: Male


Recent Publications

Title Year
Cardiac Restitution, Ion Channels, and Racehorses: A Naturally Occurring Model of Sudden Cardiac Death in Athletes2025
Accelerated ovarian failure results in brain alterations related to Alzheimer’s disease that are not recovered by high‐intensity interval training in mice2024
Tackling change: menopause as a cardiovascular disease risk factor and the path to health equity2024
ARRHYTHMOGENIC ATRIAL REMODELING DURING PREGNANCY IN MICE2024
Perimenopause Decreases SERCA2a Activity in the Hearts of a Mouse Model of Ovarian Failure2024
The effect of high intensity interval training on muscle contractile function 8 weeks following chemically-induced ovarian failure2024
Time course changes in in vivo muscle mechanical function and Ca2+ regulation of force following experimentally induced gradual ovarian failure in mice2024
Accelerated Ovarian Failure (AOF) is an Effective Transitional Menopausal Model for the Study of Alzheimer’s Disease2023
Effects of chemically induced ovarian failure on single muscle fiber contractility in a mouse model of menopause2023
Apelin receptor inhibition in ischemia-reperfused mouse hearts protected by endogenous n-3 polyunsaturated fatty acids2023
Sex differences in the cardiac stress response following SARS-CoV-2 infection of ferrets2023
Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human2023
The effect of gradual ovarian failure on dynamic muscle function and the role of high-intensity interval training on mitigating impairments2023
Abstract P3119: Identifying The Windows Of Cardiac Risk And Opportunity In Menopause2023
Predominant myosin superrelaxed state in canine myocardium with naturally occurring dilated cardiomyopathy2023
Abstract 4248: Epithelial ovarian cancer causes cardiac dysfunction and myofilament dysregulation2023
Left ventricular pseudoaneurysm without antecedent myocardial infarction2023
Innovative Animal Models Of Cardiac Remodeling: Development And Evaluation2023
A brief morning rest period benefits cardiac repair in pressure overload hypertrophy and postmyocardial infarction2022
Differential mRNA Expression and Circular RNA-Based Competitive Endogenous RNA Networks in the Three Stages of Heart Failure in Transverse Aortic Constriction Mice2022
Cardioprotective Effects of n-3 Polyunsaturated Fatty Acids: Orchestration of mRNA Expression, Protein Phosphorylation, and Lipid Metabolism in Pressure Overload Hearts2022
Recalibrating healthcare to create a more equitable post-pandemic work environment2021
A Porcine Model of Heart Failure With Preserved Ejection Fraction Induced by Chronic Pressure Overload Characterized by Cardiac Fibrosis and Remodeling2021
Effect of racing on cardiac troponin I concentration and associations with cardiac rhythm disturbances in Standardbred racehorses2021
Aged Monkeys Fed a High-Fat/High-Sugar Diet Recapitulate Metabolic Disorders and Cardiac Contractile Dysfunction2021